Guficap – Caspofungin Injection
Description
CASPOFUNGIN (GUFICAP) INJECTION – TREATMENT OF SEVERE FUNGAL INFECTIONS
Guficap Injection A prescribed antifungal is called Guficap Injection. It is used to treat extremely contagious infections. It provides relief by eliminating the parasites responsible for contaminations.
A lipopeptide antifungal drug produced by Merck and Co., Inc. is called caspofungin (INN), which goes by the brand name Cancidas. Frances A. Bouffard, Regina Black, and James Balkovec made the discovery. It belongs to a different group of antifungal drugs called echinocandins. It functions by inhibiting the enzyme (1,3)-D-glucan synthase and so disrupting the integrity of the parasite cell divider.
How Guficap Injection is used?
Guficap Injection controls a medical professional’s infusion. Kindly abstain from self-management. Regardless of how you feel, try to adhere to all dosage instructions and complete the entire course of treatment. Throughout treatment, your liver function should be monitored often.
Aspergillus and Candida species-related infectious contaminations have been successfully treated with caspofungin. It is not a member of the family of antifungal specialists known as echinocandins, which has a broad spectrum of activity against all Candida species.
Common side effects of Guficap Injection:
Guficap Injection may cause a few common side effects, including rash, decreased potassium levels in the blood, fever, increased liver catalysts, chills, and loose stools. Additionally, you can see infusion site reactions like pain, swelling, or redness. Inform your primary care doctor if these outcomes last for a longer period of time.
